Probi Ab

Goran Molin

Siv Ahrne

Bengt Jeppsson

Stig Bengmark

Bengt Jeppson

Agnes Wold

Siv Ahrné

Marie-Louise Johansson

Ingegerd Adlerberth

Caroline Karlsson

Martin Antonsson

The invention refers to a composition comprising one or more tannase-producing strains of Lactobacillus having the ability to adhere to the human intestinal mucosa in combination with tannin. New tannase-producing strains of Lactobacillus plantarum are a.

Compositions comprisingstrains in combination with tannin and newstrains

New strains ofwhich can be used as probiotics in dairy products and which are characterized in surviving the gastrointestinal passage and giving a palatable cheese product when used as an adjunct in cheese manufacturing. The invention especially refers to the new strains8700:2, DSM 13434, and02A, DSM 13432. The invention also refers to dairy food products, such as cheese, containing said strains.

[object Object]

Use of one strain offor the manufacture of a composition for increasing the diversity of the gastrointestinal tract by administration of said strain to an individual with a view to producing an increased diversity index compared to placebo is disclosed, as well as use of one strain offor the manufacture of a composition for prophylactic treatment of a healthy individual against developing a low bacterial diversity (LBD); of an individual having LBD against developing one or more physiologically disturbed conditions, large intestine bacterial overgrowth (LIBO) or small intestine bacterial overgrowth (SIBO); and of an individual having LIBO or SIBO against developing one or more physiologically disturbed conditions, and a method for increasing said diversity.

Bacterial diversity

The invention refers to new strains of, especially of the species, having the ability to survive in the intestinal tract and to produce glutamine and optionally arginine in vivo, as well as to compositions comprising said strains.

Strains of bifidobacterium having the ability to produce glutamine

Epithelial adhesive lactobacilli

A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration. By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.

Growing community of inventors

Lund, Sweden

Goran Molin